March 3, 2017
Effective immediately the shares of Abattis Bioceuticals Corp. will be reinstated for trading.
The Company has rectified the default situation that gave rise to the suspension.
Effective Date: March 3, 2017
If you have any questions or require further information please contact Listings at (416) 367-7340 or E-mail: Listings@thecse.com